Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 34
2009 39
2010 51
2011 47
2012 60
2013 49
2014 33
2015 49
2016 46
2017 46
2018 66
2019 59
2020 48
2021 66
2022 49
2023 48
2024 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

739 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic enhancers in HIV therapeutics.
Larson KB, Wang K, Delille C, Otofokun I, Acosta EP. Larson KB, et al. Clin Pharmacokinet. 2014 Oct;53(10):865-72. doi: 10.1007/s40262-014-0167-9. Clin Pharmacokinet. 2014. PMID: 25164142 Review.
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
Van Schalkwyk M, Bekker A, Decloedt E, Wang J, Theron GB, Cotton MF, Eke AC, Cressey TR, Shapiro DE, Bacon K, Knowles K, George K, Browning R, Chakhtoura N, Rungruengthanakit K, Wiesner L, Capparelli EV, Stek AM, Mirochnick M, Best BM; IMPAACT P1026s Protocol Team. Van Schalkwyk M, et al. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0073723. doi: 10.1128/aac.00737-23. Epub 2023 Oct 26. Antimicrob Agents Chemother. 2023. PMID: 37882552 Free PMC article.
HIV Transmission Through Premastication.
Nash SH, Rutledge M, Frenkel LM, Melvin AJ, Laws P, Klejka J, Hirschfeld M. Nash SH, et al. Pediatrics. 2022 Oct 1;150(4):e2021055422. doi: 10.1542/peds.2021-055422. Pediatrics. 2022. PMID: 36052601 Free PMC article.
MDR-TB in children: back to the basics.
Horsburgh CR, Gupta A. Horsburgh CR, et al. Int J Tuberc Lung Dis. 2018 May 1;22(5):1-2. doi: 10.5588/ijtld.17.0834. Int J Tuberc Lung Dis. 2018. PMID: 29665946 No abstract available.
Approaches to accelerating the study of new antiretrovirals in pregnancy.
Abrams EJ, Calmy A, Fairlie L, Mahaka IC, Chimula L, Flynn PM, Kinuthia J, Myer L, Khoo SH, Musoke P, Zwerski S, Zech JM, Lockman S, Siberry GK. Abrams EJ, et al. J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25916. doi: 10.1002/jia2.25916. J Int AIDS Soc. 2022. PMID: 35851757 Free PMC article.
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Brooks KM, Kiser JJ, Ziemba L, Ward S, Rani Y, Cressey TR, Masheto GR, Cassim H, Deville JG, Ponatshego PL, Patel F, Aurpibul L, Barnabas SL, Mustich I, Coletti A, Heckman B, Krotje C, Lojacono M, Yin DE, Townley E, Moye J, Majji S, Acosta EP, Ryan K, Chandasana H, Brothers CH, Buchanan AM, Rabie H, Flynn PM; IMPAACT 2019 Study Team. Brooks KM, et al. Lancet HIV. 2023 Aug;10(8):e506-e517. doi: 10.1016/S2352-3018(23)00107-8. Lancet HIV. 2023. PMID: 37541705 Free PMC article. Clinical Trial.
739 results